AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 28549436 — intervention group
Group type: EXPERIMENTAL
Intervention: Cross-linked sodium hyaluronate (XLHA, single injection)
Number of subjects: 287
Study 28549436 — intervention group
Group type: COMPARATOR
Intervention: High molecular weight sodium hyaluronate (HMWHA, three injections)
Number of subjects: 287
Study 25245307 — intervention group
Group type: EXPERIMENTAL
Intervention: Weight loss intervention based on portion-controlled meals
Number of subjects: 41
Study 25245307 — intervention group
Group type: COMPARATOR
Intervention: Delayed-treatment control
Number of subjects: 41
Study 23078531 — intervention group
Group type: EXPERIMENTAL
Intervention: Supervised aerobic exercise (4 times/week, 60 min/session, 60-75% of maximum heart rate)
Number of subjects: 100
Study 23078531 — intervention group
Group type: EXPERIMENTAL
Intervention: Resistance training (60-80% baseline maximum load achieved in one repetition)
Number of subjects: 100
Study 23078531 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined aerobic exercise plus resistance training
Number of subjects: 100
Study 23078531 — intervention group
Group type: COMPARATOR
Intervention: Control group (self-controlled exercise)
Number of subjects: 100
Study 20817790 — intervention group
Group type: EXPERIMENTAL
Intervention: Family oriented intervention involving family members in care, including family counselling during clinic visits, family meetings, and home visits.
Number of subjects: 243
Study 20817790 — intervention group
Group type: COMPARATOR
Intervention: Standard care (control group)
Number of subjects: 243
Study 18555517 — intervention group
Group type: EXPERIMENTAL
Intervention: Infusion of activated autologous T cells
Number of subjects: 103
Study 18555517 — intervention group
Group type: COMPARATOR
Intervention: Control group (healthy age-matched controls)
Number of subjects: 103
Study 18555517 — intervention group
Group type: COMPARATOR
Intervention: Surgery
Number of subjects: 103
Study 17031403 — intervention group
Group type: EXPERIMENTAL
Intervention: Interleukin-2 (IL-2) group; received four doses of 10 x 10(6) IU m(‐2) twice daily subcutaneously a week before operation followed by a daily maintenance dose of 3 x 10(6) IU m(‐2) subcutaneously until a day before the operation.
Number of subjects: 120
Study 17031403 — intervention group
Group type: COMPARATOR
Intervention: Control group; perioperative immunomonitoring without immunomodulation.
Number of subjects: 120
Study 17031403 — intervention group
Group type: EXPERIMENTAL
Intervention: Interleukin-2 (IL-2) group; received IL-2 treatment.
Number of subjects: 120
Study 15334869 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral glutamine (10 grams three times a day for 5 days)
Number of subjects: 36
Study 15334869 — intervention group
Group type: COMPARATOR
Intervention: Placebo (identical-appearing)
Number of subjects: 36
Study 15334869 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral glutamine
Number of subjects: 36
Study 15334869 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 36
Study 10845968 — intervention group
Group type: EXPERIMENTAL
Intervention: Interventions to change professional practice in primary care; specific details on dosage and duration not available.
Number of subjects: 0
Study 10845968 — intervention group
Group type: EXPERIMENTAL
Intervention: Experimental designs for interventions; specific details not available.
Number of subjects: 0
Study 9402502 — intervention group
Group type: EXPERIMENTAL
Intervention: Various interventions for dentine hypersensitivity (specific interventions not detailed)
Number of subjects: 0
Study 9402502 — intervention group
Group type: COMPARATOR
Intervention: Negative control
Number of subjects: 0
Study 9402502 — intervention group
Group type: COMPARATOR
Intervention: Benchmark control
Number of subjects: 0
Study 7710841 — intervention group
Group type: EXPERIMENTAL
Intervention: Dual-energy X-ray absorptiometry (DEXA)
Number of subjects: 50
Study 7710841 — intervention group
Group type: EXPERIMENTAL
Intervention: In vivo neutron activation analysis (IVNAA)
Number of subjects: 50
Study 7710841 — intervention group
Group type: EXPERIMENTAL
Intervention: Transfusion treatment
Number of subjects: 50
Study 7710841 — intervention group
Group type: EXPERIMENTAL
Intervention: Osteopenic condition
Number of subjects: 50
Study 7710841 — intervention group
Group type: EXPERIMENTAL
Intervention: DEXA
Number of subjects: 50
Study 3236318 — intervention group
Group type: EXPERIMENTAL
Intervention: Amiloride 5 mg once daily
Number of subjects: 12
Study 3236318 — intervention group
Group type: EXPERIMENTAL
Intervention: Amiloride 10 mg once daily
Number of subjects: 12
Study 3236318 — intervention group
Group type: EXPERIMENTAL
Intervention: Nitrendipine 20 mg once daily
Number of subjects: 12
Study 3236318 — intervention group
Group type: EXPERIMENTAL
Intervention: Nitrendipine 20 mg twice daily
Number of subjects: 12
Study 29307549 — intervention group
Group type: EXPERIMENTAL
Intervention: Statins
Number of subjects: 3378
Study 29307549 — intervention group
Group type: COMPARATOR
Intervention: No Statins (Control)
Number of subjects: 3378
Study 27134051 — intervention group
Group type: EXPERIMENTAL
Intervention: Micro Expression Training Tool (METT)
Number of subjects: 82
Study 27134051 — intervention group
Group type: EXPERIMENTAL
Intervention: Subtle Expression Training Tool (SETT)
Number of subjects: 82
Study 27134051 — intervention group
Group type: COMPARATOR
Intervention: Control group (no training)
Number of subjects: 82
Study 25526733 — intervention group
Group type: EXPERIMENTAL
Intervention: Everolimus (70 mg/wk) with temozolomide and radiotherapy
Number of subjects: 100
Study 23262585 — intervention group
Group type: EXPERIMENTAL
Intervention: Exogenous glucagon
Number of subjects: 0
Study 23262585 — intervention group
Group type: EXPERIMENTAL
Intervention: Reduction of Fgf-21 expression (by approximately 66%) or immunoneutralisation of released FGF-21
Number of subjects: 0
Study 21986640 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietary intake of saturated fat and cheese
Number of subjects: 92
Study 21986640 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietary intake of isoflavonoids and soy
Number of subjects: 92
Study 21986640 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietary intake of total fat and monounsaturated fat
Number of subjects: 92
Study 21986640 — intervention group
Group type: EXPERIMENTAL
Intervention: Alcohol intake
Number of subjects: 92
Study 18512581 — intervention group
Group type: EXPERIMENTAL
Intervention: Preceptor education program
Number of subjects: 0
Study 17156464 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture (up to 10 treatments over 3 months)
Number of subjects: 24
Study 17156464 — intervention group
Group type: COMPARATOR
Intervention: Usual GP care alone
Number of subjects: 24
Study 14535967 — intervention group
Group type: EXPERIMENTAL
Intervention: Metformin
Number of subjects: 390
Study 14535967 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 390
Study 10933361 — intervention group
Group type: EXPERIMENTAL
Intervention: Omapatrilat
Number of subjects: 48
Study 10933361 — intervention group
Group type: EXPERIMENTAL
Intervention: Omapatrilat (high dose)
Number of subjects: 48
Study 8881639 — intervention group
Group type: EXPERIMENTAL
Intervention: Bair Hugger
Number of subjects: 30
Study 8881639 — intervention group
Group type: COMPARATOR
Intervention: Thermomat
Number of subjects: 30
Study 8299252 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermittent high-dose pulse cyclophosphamide (Cy) and oral prednisone
Number of subjects: 23
Study 8299252 — intervention group
Group type: EXPERIMENTAL
Intervention: Daily oral low-dose cyclophosphamide (Cy) and oral prednisone
Number of subjects: 23
Study 8299252 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose co-trimoxazole therapy
Number of subjects: 23
Study 8299252 — intervention group
Group type: EXPERIMENTAL
Intervention: Mechanical ventilation
Number of subjects: 23
Study 3032814 — intervention group
Group type: EXPERIMENTAL
Intervention: Intramuscular iodinated oil given before conception
Number of subjects: 0
Study 3032814 — intervention group
Group type: EXPERIMENTAL
Intervention: Intramuscular iodinated oil
Number of subjects: 0
Study 29230878 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous Glucose Monitoring (CGM) - Dexcom G5
Number of subjects: 40
Study 29230878 — intervention group
Group type: COMPARATOR
Intervention: Flash Glucose Monitoring - Abbott Freestyle Libre
Number of subjects: 40
Study 29230878 — intervention group
Group type: EXPERIMENTAL
Intervention: CGM
Number of subjects: 40
Study 27492521 — intervention group
Group type: EXPERIMENTAL
Intervention: Endobronchial valve treatment
Number of subjects: 43
Study 27492521 — intervention group
Group type: COMPARATOR
Intervention: Standard medical care
Number of subjects: 43
Study 24013441 — intervention group
Group type: EXPERIMENTAL
Intervention: RIX4414 vaccine
Number of subjects: 3333
Study 24013441 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 3333
Study 22915277 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-set goal for final balance (n=25)
Number of subjects: 100
Study 22915277 — intervention group
Group type: EXPERIMENTAL
Intervention: Presentation of an anchor (n=25)
Number of subjects: 100
Study 22915277 — intervention group
Group type: EXPERIMENTAL
Intervention: Anchor and goal definition (n=25)
Number of subjects: 100
Study 22915277 — intervention group
Group type: COMPARATOR
Intervention: Neither anchor nor goal setting (n=25)
Number of subjects: 100
Study 21055140 — intervention group
Group type: EXPERIMENTAL
Intervention: Elastic bandage group (ER)
Number of subjects: 2910
Study 21055140 — intervention group
Group type: EXPERIMENTAL
Intervention: T band group (TB)
Number of subjects: 2910
Study 21055140 — intervention group
Group type: EXPERIMENTAL
Intervention: Balloon group (TR)
Number of subjects: 2910
Study 18487889 — intervention group
Group type: EXPERIMENTAL
Intervention: Tai Chi (TC) training
Number of subjects: 19
Study 18487889 — intervention group
Group type: COMPARATOR
Intervention: Control training (axial exercises, balance awareness/education, stress reduction)
Number of subjects: 19
Study 15990748 — intervention group
Group type: EXPERIMENTAL
Intervention: Rate-control strategy
Number of subjects: 4060
Study 15990748 — intervention group
Group type: COMPARATOR
Intervention: Rhythm-control strategy
Number of subjects: 4060
Study 12922040 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultra-early decompressive craniectomy (less than 6 hours)
Number of subjects: 52
Study 12922040 — intervention group
Group type: COMPARATOR
Intervention: Craniectomy beyond 6 hours
Number of subjects: 52
Study 12922040 — intervention group
Group type: COMPARATOR
Intervention: No operation
Number of subjects: 52
Study 12922040 — intervention group
Group type: COMPARATOR
Intervention: Diagnosis by CT
Number of subjects: 52
Study 12922040 — intervention group
Group type: EXPERIMENTAL
Intervention: Diagnosis by DWI
Number of subjects: 52
Study 10737271 — intervention group
Group type: EXPERIMENTAL
Intervention: Large amplitude (30 cm)
Number of subjects: 3
Study 10737271 — intervention group
Group type: EXPERIMENTAL
Intervention: Medium amplitude (22.5 cm)
Number of subjects: 3
Study 10737271 — intervention group
Group type: EXPERIMENTAL
Intervention: Small amplitude (15 cm)
Number of subjects: 3
Study 10737271 — intervention group
Group type: EXPERIMENTAL
Intervention: Practice
Number of subjects: 3
Study 10737271 — intervention group
Group type: EXPERIMENTAL
Intervention: Transfer tests
Number of subjects: 3
Study 8853757 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 mg omeprazole daily for 9 days
Number of subjects: 33
Study 8853757 — intervention group
Group type: EXPERIMENTAL
Intervention: 40 mg omeprazole daily for 9 days
Number of subjects: 33
Study 8853757 — intervention group
Group type: EXPERIMENTAL
Intervention: Long-term therapy with omeprazole (mean duration 56 months) in GERD patients
Number of subjects: 33
Study 1735850 — intervention group
Group type: EXPERIMENTAL
Intervention: Synthetic surfactant Exosurf Neonatal
Number of subjects: 0
Study 1735850 — intervention group
Group type: COMPARATOR
Intervention: Air placebo
Number of subjects: 0
Study 3883917 — intervention group
Group type: EXPERIMENTAL
Intervention: Etretinate (Tigason) up to 0.5 mg/kg/day
Number of subjects: 20
Study 3883917 — intervention group
Group type: COMPARATOR
Intervention: Ibuprofen
Number of subjects: 20
Study 30153464 — intervention group
Group type: EXPERIMENTAL
Intervention: 13-min daily guided meditation session for 8 weeks
Number of subjects: 0
Study 30153464 — intervention group
Group type: COMPARATOR
Intervention: 13-min daily podcast listening session (control group) for 8 weeks
Number of subjects: 0
Study 29397160 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietary counseling intervention
Number of subjects: 554
Study 27221676 — intervention group
Group type: EXPERIMENTAL
Intervention: Medial canthal vertical incision
Number of subjects: 40
Study 27221676 — intervention group
Group type: EXPERIMENTAL
Intervention: Subciliary incision
Number of subjects: 40
Study 27221676 — intervention group
Group type: EXPERIMENTAL
Intervention: Prolene 6‐0 suture
Number of subjects: 40
Study 27221676 — intervention group
Group type: COMPARATOR
Intervention: Vicryl 6‐0 suture
Number of subjects: 40
Study 27221676 — intervention group
Group type: EXPERIMENTAL
Intervention: Pediatric patients
Number of subjects: 40
Study 27221676 — intervention group
Group type: EXPERIMENTAL
Intervention: Dark-skinned patients
Number of subjects: 40
Study 24270743 — intervention group
Group type: EXPERIMENTAL
Intervention: High-sensitivity cardiac troponin I (cTnI) Stratus CS
Number of subjects: 850
Study 24270743 — intervention group
Group type: EXPERIMENTAL
Intervention: High-sensitivity cardiac troponin I (cTnI) Beckmann
Number of subjects: 850
Study 24270743 — intervention group
Group type: EXPERIMENTAL
Intervention: High-sensitivity cardiac troponin I (cTnI) Siemens ultra
Number of subjects: 850
Study 24270743 — intervention group
Group type: EXPERIMENTAL
Intervention: High-sensitivity cardiac troponin T
Number of subjects: 850
Study 24270743 — intervention group
Group type: EXPERIMENTAL
Intervention: Heart fatty acid binding protein (HFABP)
Number of subjects: 850
Study 24270743 — intervention group
Group type: EXPERIMENTAL
Intervention: Copeptin
Number of subjects: 850
Study 24270743 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of HFABP and troponin
Number of subjects: 850
Study 22095207 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard rehabilitation plus NMES applied to the quadriceps muscle, initiated 48 hours after surgery, applied twice per day at maximum tolerable intensity for 15 contractions.
Number of subjects: 66
Study 22095207 — intervention group
Group type: COMPARATOR
Intervention: Standard rehabilitation (control).
Number of subjects: 66
Study 20393696 — intervention group
Group type: EXPERIMENTAL
Intervention: Glycyrrhizin
Number of subjects: 16
Study 20393696 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study 18663117 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound (1 MHz, 0.5 W/cm(2)) once daily, six times a week for seven weeks (Groups 1 and 3)
Number of subjects: 81
Study 18663117 — intervention group
Group type: COMPARATOR
Intervention: Control group (Group 4)
Number of subjects: 81
Study 18663117 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgical treatment (Groups 1 and 2)
Number of subjects: 81
Study 18663117 — intervention group
Group type: EXPERIMENTAL
Intervention: Conservative treatment with ultrasound (Group 3)
Number of subjects: 81
Study 16351668 — intervention group
Group type: EXPERIMENTAL
Intervention: EZE/SIMVA 10/20 mg/day
Number of subjects: 435
Study 16351668 — intervention group
Group type: COMPARATOR
Intervention: ATV 20 mg/day
Number of subjects: 435
Study 11915724 — intervention group
Group type: EXPERIMENTAL
Intervention: Extended lymphatic and connective tissue clearance during surgical resection
Number of subjects: 0
Study 11915724 — intervention group
Group type: EXPERIMENTAL
Intervention: Extended surgery
Number of subjects: 0
Study 11915724 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgery combined with chemo- and/or radiation therapies
Number of subjects: 0
Study 10342337 — intervention group
Group type: EXPERIMENTAL
Intervention: Humalog insulin
Number of subjects: 20
Study 10342337 — intervention group
Group type: COMPARATOR
Intervention: Human soluble insulin
Number of subjects: 20
Study 7856899 — intervention group
Group type: EXPERIMENTAL
Intervention: Desflurane (1.25 MAC)
Number of subjects: 16
Study 7856899 — intervention group
Group type: COMPARATOR
Intervention: Isoflurane (1.25 MAC)
Number of subjects: 16
Study 7856899 — intervention group
Group type: EXPERIMENTAL
Intervention: Desflurane (100 micrograms/kg vecuronium)
Number of subjects: 16
Study 7856899 — intervention group
Group type: COMPARATOR
Intervention: Isoflurane (100 micrograms/kg vecuronium)
Number of subjects: 16
Study 7856899 — intervention group
Group type: EXPERIMENTAL
Intervention: Desflurane (reduction from 1.25 to 0.75 MAC)
Number of subjects: 16
Study 7856899 — intervention group
Group type: COMPARATOR
Intervention: Isoflurane (reduction from 1.25 to 0.75 MAC)
Number of subjects: 16
Study 7856899 — intervention group
Group type: EXPERIMENTAL
Intervention: Desflurane (reduction from 0.75 to 0.25 MAC)
Number of subjects: 16
Study 7856899 — intervention group
Group type: COMPARATOR
Intervention: Isoflurane (reduction from 0.75 to 0.25 MAC)
Number of subjects: 16
Study 7856899 — intervention group
Group type: EXPERIMENTAL
Intervention: Desflurane (90% response time)
Number of subjects: 16
Study 7856899 — intervention group
Group type: COMPARATOR
Intervention: Isoflurane (90% response time)
Number of subjects: 16
Study 1940682 — intervention group
Group type: EXPERIMENTAL
Intervention: Lower cervical adjustments
Number of subjects: 0
Study 1940682 — intervention group
Group type: COMPARATOR
Intervention: Sham-adjusted controls
Number of subjects: 0
Study 6102915 — intervention group
Group type: EXPERIMENTAL
Intervention: Zopiclone 7.5 mg
Number of subjects: 414
Study 6102915 — intervention group
Group type: EXPERIMENTAL
Intervention: Nitrazepam 5 mg
Number of subjects: 414
Study 6102915 — intervention group
Group type: EXPERIMENTAL
Intervention: Flurazepam 30 mg
Number of subjects: 414
Study 6102915 — intervention group
Group type: EXPERIMENTAL
Intervention: Flunitrazepam 2 mg
Number of subjects: 414
Study 6102915 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 414
Study 31537702 — intervention group
Group type: EXPERIMENTAL
Intervention: Macrolide treatment
Number of subjects: 4898
Study 31537702 — intervention group
Group type: COMPARATOR
Intervention: Standard of care
Number of subjects: 4898
Study 27811307 — intervention group
Group type: EXPERIMENTAL
Intervention: Stent retriever (Trevo)
Number of subjects: 0
Study 27811307 — intervention group
Group type: COMPARATOR
Intervention: Merci device
Number of subjects: 0
Study 25036870 — intervention group
Group type: EXPERIMENTAL
Intervention: 3.2% hypertonic saline (HTS)
Number of subjects: 74
Study 25036870 — intervention group
Group type: COMPARATOR
Intervention: 20% mannitol
Number of subjects: 74
Study 25027478 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy (CBT) for 16 weeks
Number of subjects: 21
Study 25027478 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Remediation Therapy for 8 weeks followed by Cognitive Behavioral Therapy for 8 weeks
Number of subjects: 21
Study 25027478 — intervention group
Group type: COMPARATOR
Intervention: Control group (not explicitly mentioned)
Number of subjects: 21
Study 22951349 — intervention group
Group type: EXPERIMENTAL
Intervention: Electrically Heated Cigarette Smoking System (EHCSS-K6)
Number of subjects: 316
Study 22951349 — intervention group
Group type: COMPARATOR
Intervention: Conventional cigarettes (CC)
Number of subjects: 316
Study 19317065 — intervention group
Group type: EXPERIMENTAL
Intervention: Magnesium group (MgSO4 30 mg/kg in saline)
Number of subjects: 30
Study 19317065 — intervention group
Group type: COMPARATOR
Intervention: Control group (saline without MgSO4)
Number of subjects: 30
Study 17410461 — intervention group
Group type: EXPERIMENTAL
Intervention: Omeprazole 10 mg once daily (od)
Number of subjects: 7
Study 17410461 — intervention group
Group type: EXPERIMENTAL
Intervention: Omeprazole 20 mg once daily (od)
Number of subjects: 7
Study 17410461 — intervention group
Group type: EXPERIMENTAL
Intervention: Omeprazole 40 mg once daily (od)
Number of subjects: 7
Study 17410461 — intervention group
Group type: EXPERIMENTAL
Intervention: Omeprazole 10 mg twice daily (bid)
Number of subjects: 7
Study 17410461 — intervention group
Group type: EXPERIMENTAL
Intervention: Omeprazole 20 mg twice daily (bid)
Number of subjects: 7
Study 15626258 — intervention group
Group type: EXPERIMENTAL
Intervention: Cocaine flakes
Number of subjects: 220
Study 15626258 — intervention group
Group type: COMPARATOR
Intervention: Tetracaine/adrenaline solution
Number of subjects: 220
Study 11223706 — intervention group
Group type: EXPERIMENTAL
Intervention: CC + ethinyl estradiol (0.05 mg)
Number of subjects: 50
Study 11223706 — intervention group
Group type: EXPERIMENTAL
Intervention: CC + ethinyl estradiol (0.02 mg)
Number of subjects: 50
Study 11223706 — intervention group
Group type: COMPARATOR
Intervention: Clomiphene citrate (CC)
Number of subjects: 50
Study 9849273 — intervention group
Group type: EXPERIMENTAL
Intervention: Dorsal Penile Nerve Block (DPNB)
Number of subjects: 20
Study 9849273 — intervention group
Group type: COMPARATOR
Intervention: Eutectic Mixture of Local Anesthetic (EMLA)
Number of subjects: 20
Study 8014393 — intervention group
Group type: EXPERIMENTAL
Intervention: Arginine vasopressin (AVP) 3 x 10 IU in each nostril
Number of subjects: 50
Study 8014393 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study 2811377 — intervention group
Group type: EXPERIMENTAL
Intervention: Vaginal oestriol (E3) therapy at a dose of 0.5 mg per day
Number of subjects: 29
Study 2811377 — intervention group
Group type: COMPARATOR
Intervention: Vaginal oestradiol (E2) therapy at a dose of 0.05 mg per day
Number of subjects: 29
Study 2811377 — intervention group
Group type: COMPARATOR
Intervention: Untreated postmenopausal women
Number of subjects: 29
Study 2811377 — intervention group
Group type: EXPERIMENTAL
Intervention: Vaginal E3 therapy
Number of subjects: 29
Study 2811377 — intervention group
Group type: COMPARATOR
Intervention: Endometrium
Number of subjects: 29
Study 2811377 — intervention group
Group type: COMPARATOR
Intervention: Endometrium vs Myometrium and Vagina
Number of subjects: 29
Study 2811377 — intervention group
Group type: COMPARATOR
Intervention: Vagina and Uterus
Number of subjects: 29
Study 875465 — intervention group
Group type: EXPERIMENTAL
Intervention: Bupicomide
Number of subjects: 6
Study 875465 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydralazine
Number of subjects: 6
Study 31438878 — intervention group
Group type: EXPERIMENTAL
Intervention: Magnesium sulfate (MgSO4) infusion for 72 hours
Number of subjects: 26
Study 31438878 — intervention group
Group type: COMPARATOR
Intervention: Placebo infusion for 72 hours
Number of subjects: 26